Chemicals

AESGP feedback on the View
Chemicals

AESGP feedback on the "One Substance, One Assessment" legislative package (2024)

Read more
AESGP Feedback to proposed PFAS restriction by ECHA (2023) View
Chemicals

AESGP Feedback to proposed PFAS restriction by ECHA (2023)

Read more
Human Health Medicinal Products Sector Survey: Impact of Proposed PFAS Restriction on Patient Access to Medicines & EU Strategic Autonomy (2023) View
Chemicals

Human Health Medicinal Products Sector Survey: Impact of Proposed PFAS Restriction on Patient Access to Medicines & EU Strategic Autonomy (2023)

Read more